Fleroxacin Production Cost Reports

The report provides a detailed analysis essential for establishing a Fleroxacin production plant. It encompasses all critical aspects necessary for Fleroxacin production, including the cost of Fleroxacin production, Fleroxacin plant cost, Fleroxacin production costs, and the overall Fleroxacin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Fleroxacin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Fleroxacin, a fluoroquinolone antibiotic, is mainly utilised in pharmaceutical production to produce broad-spectrum antimicrobials targeting urinary tract infections, respiratory infections, gonorrhoea, bacterial enteritis, and traveller’s diarrhoea. Its excellent oral bioavailability (95-100%) and long half-life enable once-daily dosing formulations.

Beyond clinical antibiotics, ongoing industrial applications includes exploring non-classical roles in anti-tumour, anti-tuberculosis, and anti-malarial synthesis routes, along with supply for lab reagents and API production.

Fleroxacin market growth is driven by surging bacterial infection rates, especially urinary tract and respiratory cases, coupled with expanding healthcare infrastructure. Additionally, ageing populations, elevated healthcare spending, and antimicrobial stewardship programs favouring broad-spectrum fluoroquinolones boost the market growth. Moreover, R&D investments in advanced formulations and generics, government efforts against antimicrobial resistance, regulatory support, personalised medicine trends, and pharmaceutical collaborations amid shifts to outpatient care contribute to the market growth.

Industrial Fleroxacin procurement in the pharmaceutical industry is influenced by stringent quality assurance requirements, including high purity levels, GMP certification, and compliance with regulatory standards from bodies like the FDA or EMA, ensuring traceability via Certificates of Analysis (CoA). Furthermore, fluctuations in the cost and availability of the major raw materials utilised in the production process (6,7,8-trifluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 1-methylpiperazine, and pyridine) also impact the overall procurement.

Raw Material for Fleroxacin Production

According to the Fleroxacin production plant project report, the various raw materials for Fleroxacin production include 6,7,8-trifluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 1-methylpiperazine | pyridine.

Production Process of Fleroxacin

The extensive Fleroxacin production cost report consists of the following major industrial production process:

1. Production via a nucleophilic aromatic substitution: The production process of Fleroxacin occurs via a nucleophilic aromatic substitution reaction. In this process, 6,7,8-trifluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid reacts with excess 1-methylpiperazine in pyridine under reflux for 6 hours, selectively displacing the 7-fluoro substituent to install the piperazinyl group at the quinolone 7-position. The crude product undergoes solvent removal, cooling, filtration, and recrystallisation from water, producing Fleroxacin as the final product.

Properties of Fleroxacin

Fleroxacin (C17H18F3N3O3, molecular weight 369.34 g/mol) appears as a white to pale yellow crystalline powder with poor water solubility but good solubility in acidic aqueous solutions, enabling hydrochloride salt formation for pharmaceutical use. Its chemical structure consists of a 4-quinolone core with fluoro substituents at C6 and C8, a 2-fluoroethyl group at N1, and a 4-methylpiperazin-1-yl at C7, contributing to broad-spectrum antibacterial activity via DNA gyrase inhibition, alongside descriptors like XLogP3 -0.1, TPSA 64.1 Ų, 1 H-bond donor, 9 acceptors, and 4 rotatable bonds. It has a melting point in the range of 269-271 degree Celsius (decomp.) for the HCl salt, high oral bioavailability (95-100%), and stability challenges under photodegradation, prompting light-protected handling in production.